543245 announcements Gland announcements and dividends declared BSE
Gland Complete list of announcements declared & dividend announcements by Gland 543245
Gland 543245 listed on BSE and deals inAnnouncements and dividends declared by Gland 543245
Gland Pharma soars 7% on USFDA approval for breast cancer drug
The Eribulin Mesylate injection is indicated for treating patients diagnosed with metastatic breast cancer (mBC) who have undergone at least two rounds of chemotherapy for managing metastatic disease
Announcement as on 08 April 2024
Gland Pharma gets USFDA nod for generic breast cancer drug
Gland Pharma has received approval from the USFDA to market a generic medication for breast cancer treatment, Eribulin Mesylate Injection. It's expected to be the first generic approval in the market, with sales of around USD 92 million in the US.
Announcement as on 08 April 2024
Two entities likely to sell 4.4% stake in Gland Pharma via block deals: Report
Nicomac Machinery and RP Advisory Services ​are looking at raising Rs 1,400 crore through the sale, and have set the floor price for the same at Rs 1,725/share. The floor price is at a discount of over 7% to the current market price of the stock. On Mond
Announcement as on 08 April 2024
Gland Pharma receives USFDA approval for Eribulin Mesylate Injection
Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for Eribulin Mesylate Injection, 0.5 mg/mL Single Dose Vial (Product).
Announcement as on 06 April 2024
Bank of England steps up scrutiny of private equity and bank valuations
​The Bank of England said on Wednesday it was taking a deeper look at risks from the opaque private equity sector, and why valuations of Britain's main banks are "subdued" compared with international peers.
Announcement as on 27 March 2024
Announcements by Gland first page | Next page | Prev page |
543245 Gland current price & indicator signals
Recent prices of 543245 Gland are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 10 Fri Apr 2026 | 1739.85 | 1730.90 to 1770.00 | -0.35% | 1.28 times |
| 09 Thu Apr 2026 | 1746.00 | 1722.80 to 1754.10 | 0.97% | 0.15 times |
| 08 Wed Apr 2026 | 1729.20 | 1710.20 to 1781.95 | 0.89% | 0.09 times |
| 07 Tue Apr 2026 | 1713.95 | 1671.85 to 1720.00 | 0.79% | 0.24 times |
| 06 Mon Apr 2026 | 1700.50 | 1665.65 to 1734.50 | 0.62% | 2.13 times |
| 02 Thu Apr 2026 | 1689.95 | 1650.20 to 1706.05 | -0.98% | 5.73 times |
| 01 Wed Apr 2026 | 1706.65 | 1661.20 to 1734.15 | 0.55% | 0.46 times |
| 30 Mon Mar 2026 | 1697.30 | 1616.00 to 1718.35 | -1.82% | 0.54 times |
| 27 Fri Mar 2026 | 1728.75 | 1680.05 to 1794.40 | 1.16% | 0.25 times |
| 25 Wed Mar 2026 | 1708.90 | 1681.95 to 1728.30 | 2.42% | 0.25 times |
| 24 Tue Mar 2026 | 1668.45 | 1617.45 to 1679.95 | 3.51% | 0.16 times |
| 23 Mon Mar 2026 | 1611.95 | 1597.45 to 1639.55 | -0.82% | 0.09 times |
Videos related to: 543245 announcements Gland announcements and dividends declared BSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- BSE Screeners
- BSE Daily Screener
- BSE Weekly Screener
- BSE Monthly Screener
- Support & Resistance
- BSE Shares Near Support
- BSE Shares Near Resistance


